Maven Capital Partners and YFM Equity Partners have completed a £6.5m Series A investment into Manchester-based BioTech innovator Biorelate. Founded in 2014 and led by Daniel Jamieson, Biorelate curates dark biomedical knowledge to empower drug discovery with its proprietary AI platform, Galactic AI. Galactic AI’s innovative technology uniquely combines natural language processing (NLP) and machine … Continue reading BioTech innovator eyes US after £6.5m investment